Acquirer Profile
Gilead Sciences Acquisitions & Deals (2026)
Biotechnology
Deals tracked
3
Combined value
$15.0B
Primary sector
Biotechnology
Active
2026
FireStrike tracks every Gilead Sciences acquisition, merger, and strategic investment in real time. This page covers 3 Gilead Sciences deals totaling $15.0B in disclosed deal value, spanning Biotechnology. Data covers 2026.
Gilead Sciences Acquisitions — Full List
| Target company | Announced | Source |
|---|---|---|
Arcellx biotechnology | Apr 2026 | |
Tubulis Biotechnology | Apr 2026 | |
Ouro Medicines Biotechnology | Mar 2026 |
Gilead Sciences Acquisitions — FAQ
How many acquisitions has Gilead Sciences made?
Gilead Sciences has made 3 acquisitions and deals tracked on FireStrike, totaling $15.0B in combined deal value.
What sectors does Gilead Sciences acquire in?
Gilead Sciences primarily acquires in Biotechnology.
What is Gilead Sciences's most recent acquisition?
Gilead Sciences's most recent tracked acquisition is Arcellx for $7.8B, announced Apr 2026.
Get every Gilead Sciences deal in your inbox
FireStrike tracks M&A, IPOs, and fundraises daily — free.
Start tracking free →